Huili Lu

Title: Huili Lu: Innovator in Hybrid Ligand Technology

Introduction

Huili Lu is a prominent inventor based in Zhejiang, China. She has made significant contributions to the field of chromatography through her innovative research and development. Her work focuses on hybrid ligands and biomimetic materials, which have important applications in antibody separation.

Latest Patents

Huili Lu holds a patent for a "Hybrid ligand, hybrid biomimetic chromedia and preparing method and use thereof." This invention relates to a hybrid ligand and a hybrid biomimetic chromedia that utilizes hydrophilic porous microspheres as a substrate in chromatography. The process involves activation with allyl bromide, followed by bromo-alcoholization with N-bromosuccinimide, and coupling with hybrid ligands. The sequence of the hybrid ligand includes phenylalanine-tyrosine-glutamine-5-aminobenzimidazole. This innovative chromedia combines the functional groups of a tripeptide and aminobenzimidazole, maintaining high antibody selectivity while introducing a hydrophobic electric charge inductive ligand for more moderate elution requirements. This advancement enables effective antibody separation.

Career Highlights

Huili Lu is affiliated with Zhejiang University, where she continues her research and development in the field of biomimetic materials. Her work has garnered attention for its potential to enhance the efficiency of antibody separation processes.

Collaborations

Huili collaborates with notable colleagues, including Shanjing Yao and Dongqiang Lin, who contribute to her research endeavors and help advance the field of chromatography.

Conclusion

Huili Lu's innovative work in hybrid ligand technology represents a significant advancement in chromatography. Her contributions are poised to impact the efficiency of antibody separation, showcasing the importance of research in this field.